We prepared three variants of nintedanib dry powder inhalations (DPIs), one with dibasic calcium phosphate dihydrate (CaHPO·2HO) and two with lactose monohydrate as the carrier. CaHPO is not reported as a DPI excipient. We compared nintedanib pharmacokinetics and efficacy of the CaHPO formulation against bleomycin-induced pulmonary fibrosis following oral (3.
View Article and Find Full Text PDF